Global Herpes Treatment Market 2017-2021

Publisher Name :
Date: 14-Jun-2017
No. of pages: 82
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Herpesviruses belong to double-stranded DNA viruses, which are responsible for a large number of diseases in humans and animals. There are eight types of human herpesvirus (HHV) that affects humans. Among these, herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most commonly found HHVs that causes severe infections in humans. HSV is further segmented into oral herpes and genital herpes.

The analysts forecast global herpes treatment market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global herpes treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs in herpes treatment market.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


The report, Global Herpes Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Gilead

  • GlaxoSmithKline

  • Merck

  • Novartis


Other prominent vendors


  • Abbott

  • Agenus

  • Genocea

  • Mylan

  • Teva Pharmaceutical Industries

  • Vical


Market driver


  • Increasing prevalence of herpes infection

  • For a full, detailed list, view our report


Market challenge


  • Side effects of drugs

  • For a full, detailed list, view our report


Market trend


  • Emergence of novel therapies

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

  • What are the market opportunities and threats faced by the key vendors?

  • What are the strengths and weaknesses of the key vendors?

Avail $1000 Discount on this report till 31 August 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Herpes Treatment Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
Market outline
Disease overview

PART 05: Market introduction
Market overview
Market size and forecast
Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by virus type
Herpes simplex
Herpes zoster

PART 08: Geographical segmentation
Herpes treatment market in Americas
Herpes treatment market in EMEA
Herpes treatment market in APAC

PART 09: Key leading count

PART 10: Drivers and challenges
Market drivers
Market challenges

PART 11: Market trends
Emergence of novel therapies
Increasing focus on vaccine development
Increasing focus on drug development for pre-adolescent patients

PART 12: Vendor landscape
Competitive scenario

PART 13: Key vendor analysis
Gilead
GlaxoSmithKline
Merck
Novartis
Other prominent vendors

PART 14: Appendix
List of abbreviations

List of Exhibits

Exhibit 01: Types of HHV
Exhibit 02: Symptoms of herpesvirus infection
Exhibit 03: Diagnosis and treatment of herpes
Exhibit 04: Global herpes treatment market snapshot
Exhibit 05: Global herpes treatment market 2016-2021 ($ millions)
Exhibit 06: Opportunity analysis: Global herpes treatment market
Exhibit 07: Five forces analysis
Exhibit 08: Key pipeline molecules by vendors
Exhibit 09: Key clinical trials
Exhibit 10: Global herpes treatment market by virus type
Exhibit 11: Global HSV treatment market
Exhibit 12: Market overview: Global HSV treatment market
Exhibit 13: Global oral herpes treatment market 2016-2021 ($ millions)
Exhibit 14: Global share of HSV-2 infection
Exhibit 15: Global genital herpes treatment market 2016-2021 ($ millions)
Exhibit 16: Global herpes zoster treatment market 2016-2021 ($ millions)
Exhibit 17: Segmentation of global herpes treatment market by geography 2016 and 2021
Exhibit 18: Global herpes treatment market revenue by geography 2016-2021 ($ millions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Herpes treatment market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Herpes treatment market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario of APAC
Exhibit 24: Herpes treatment market in APAC 2016-2021 ($ millions)
Exhibit 25: Population at a higher risk of herpes
Exhibit 26: Percentage distribution of organ transplants in US 1988-2016
Exhibit 27: Competitive structure analysis of global herpes treatment market 2016
Exhibit 28: Strategic success factors of companies in global herpes treatment market
Exhibit 29: Gilead: Key highlights
Exhibit 30: Gilead: Strength assessment
Exhibit 31: Gilead: Strategy assessment
Exhibit 32: Gilead: Opportunity assessment
Exhibit 33: GlaxoSmithKline: Key highlights
Exhibit 34: GlaxoSmithKline: Strength assessment
Exhibit 35: GlaxoSmithKline: Strategy assessment
Exhibit 36: GlaxoSmithKline: Opportunity assessment
Exhibit 37: Merck: Key highlights
Exhibit 38: Merck: Strength assessment
Exhibit 39: Merck: Strategy assessment
Exhibit 40: Merck: Opportunity assessment
Exhibit 41: Novartis: Key highlights
Exhibit 42: Novartis: Strength assessment
Exhibit 43: Novartis: Strategy assessment
Exhibit 44: Novartis: Opportunity assessment

  • Global Amoxicillin Market Professional Survey Report 2017
    Published: 09-Aug-2017        Price: US 3500 Onwards        Pages: 110
    This report studies Amoxicillin in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Eli Lilly and Company - Merck - Antibioticos - Sandoz - GSK......
  • Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 45
    Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2017, provides an overview of the Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline landscape. Shigella Infections (Shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramp......
  • Osteomyelitis - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 47
    Osteomyelitis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Pipeline Review, H2 2017, provides an overview of the Osteomyelitis (Infectious Disease) pipeline landscape. Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Symptoms include fever, pain in the area of the infection, s......
  • Coccidioidomycosis - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 43
    Coccidioidomycosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Coccidioidomycosis - Pipeline Review, H2 2017, provides an overview of the Coccidioidomycosis (Infectious Disease) pipeline landscape. Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache, fatigue and joint aches. R......
  • Cryptococcosis - Pipeline Review, H2 2017
    Published: 08-Aug-2017        Price: US 2000 Onwards        Pages: 34
    Cryptococcosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptococcosis - Pipeline Review, H2 2017, provides an overview of the Cryptococcosis (Infectious Disease) pipeline landscape. Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, head ache, nausea and skin rashes. Predisposing factors are most often seen in people ......
  • United States Cephalosporin Drugs Market Report 2017
    Published: 31-Jul-2017        Price: US 3800 Onwards        Pages: 107
    In this report, the United States Cephalosporin Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate......
  • Global Antibiotics Market Research Report 2017-2022 By Players, Regions, Product Types & Applications
    Published: 31-Jul-2017        Price: US 2380 Onwards        Pages: 129
    The global Antibiotics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report offers an overview of the market trends, drivers, and barriers with respect to the Antibiotics market. It also provides a detailed overview of the market of different regions across United States, Europe, China, Japan, India, Southeast Asia and Others. The report categorizes Antibiotics market by P......
  • Sinusitis - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Sinusitis -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Sinusitis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Sinusitis. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Sinusitis. The report contains the targeted patient populations and the forecast methodolog......
  • Shigella Infections - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 28-Jul-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Shigella Infections - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Shigella Infections for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Shigella Infections . It enables understanding......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs